Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status

Kidney International

Volumn 83, Issue 4, 2013, Pages 662-673

  Nishi, Yuko ^a   Satoh, Minoru ^a   Nagasu, Hajime ^a   Kadoya, Hiroyuki ^a   Ihoriya, Chieko ^a   Kidokoro, Kengo ^a   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

free fatty acid; inflammasome; mitochondrial stress; oxidation

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CRYOPYRIN; CYTOCHROME C OXIDASE; FATTY ACID; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; MITOCHONDRIAL RESPIRATION; MORPHOLOGY; MOUSE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RESPIRATORY FUNCTION; SEX DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

EID: 84875730197     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.475     Document Type: Article

References (47)

1. Iseki K, Ikemiya Y, Iseki C et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474.
2. Yamagata K, Ishida K, Sairenchi T et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166.
3. Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 2001; 280: F562-F573.
4. Sweetser DA, Heuckeroth RO, Gordon JI. The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr 1987; 7: 337-359.
5. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991; 1081: 1-24.
6. Erkan E, Devarajan P, Schwartz GJ. Mitochondria are the major targets in albumin-induced apoptosis in proximal tubule cells. J Am Soc Nephrol 2007; 18: 1199-1208.
7. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5(Suppl A): S3-S10.
8. Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat Rev Nephrol 2009; 5: 384-396.
9. Mankhey RW, Wells CC, Bhatti F et al. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 2007; 292: R769-777.
10. Chin M, Isono M, Isshiki K et al. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am J Pathol 2005; 166: 1629-1636.
11. Klinge CM. Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem 2008; 105: 1342-1351.
12. Duckles SP, Krause DN. Mechanisms of cerebrovascular protection: estrogen, inflammation and mitochondria. Acta Physiol (Oxf) 2011; 203: 149-154.
13. Melamed ML, Blackwell T, Neugarten J et al. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int 2011; 79: 241-249.
14. Ogura A, Asano T, Matsuda J et al. Characteristics of mutant mice (ICGN) with spontaneous renal lesions: a new model for human nephrotic syndrome. Lab Anim 1989; 23: 169-174.
15. Smith RA, Adlam VJ, Blaikie FH et al. Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 2008; 1147: 105-111.
16. Vegeto E, Cuzzocrea S, Crisafulli C et al. Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation. Endocrinology 2010; 151: 174-184.
17. Zou A, Marschke KB, Arnold KE et al. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Mol Endocrinol 1999; 13: 418-430.
18. Krid H, Dorison A, Salhi A et al. Expression profile of nuclear receptors along male mouse nephron segments reveals a link between ERRbeta and thick ascending limb function. PLoS One 2012; 7: e34223.
19. Rogers JL, Mitchell AR, Maric C et al. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R794-799.
20. Santollo J, Wiley MD, Eckel LA. Acute activation of ER alpha decreases food intake, meal size, and body weight in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R2194-2201.
21. Meli R, Pacilio M, Raso GM et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004; 145: 3115-3121.
22. Meng Q, Wong YT, Chen J et al. Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer 344 rats. Mech Ageing Dev 2007; 128: 286-292.
23. Ishola DA Jr., Post JA, van Timmeren MM et al. Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 2006; 70: 724-731.
24. Nicolson GL. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem 2007; 100: 1352-1369.
25. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
26. Maher AC, Akhtar M, Tarnopolsky MA. Men supplemented with 17beta-estradiol have increased beta-oxidation capacity in skeletal muscle. Physiol Genomics 2010; 42: 342-347.
27. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994; 45: 1697-1709.
28. Kamijo Y, Hora K, Kono K et al. PPARalpha protects proximal tubular cells from acute fatty acid toxicity. J Am Soc Nephrol 2007; 18: 3089-3100.
29. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455.
30. Fauconnier J, Andersson DC, Zhang SJ et al. Effects of palmitate on Ca(2\+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 2007; 56: 1136-1142.
31. Koyama T, Kume S, Koya D et al. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med 2011; 51: 1258-1267.
32. Murali NS, Ackerman AW, Croatt AJ et al. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 2007; 292: F837-844.
33. Morigi M, Macconi D, Zoja C et al. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 2002; 13: 1179-1189.
34. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol 2011; 22: 1007-1018.
35. Kanaguchi Y, Suzuki Y, Osaki K et al. Protective effects of L-type fatty acidbinding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol Dial Transplant 2011; 26: 3465-3473.
36. Kepp O, Galluzzi L, Kroemer G. Mitochondrial control of the NLRP3 inflammasome. Nat Immunol 2011; 12: 199-200.
37. Kawakami T, Inagi R, Takano H et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant 2009; 24: 2665-2672.
38. Ohse T, Inagi R, Tanaka T et al. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int 2006; 70: 1447-1455.
39. Yeretssian G, Doiron K, Shao W et al. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci USA 2009; 106: 9016-9020.
40. Fink SL, Cookson BT. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 2006; 8: 1812-1825.
41. Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 2010; 19: 393-402.
42. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14: 281-287.
43. Namikoshi T, Tomita N, Satoh M et al. Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein. Am J Hypertens 2007; 20: 1085-1091.
44. Ketteler M, Westenfeld R, Gawlik A et al. Nitric oxide synthase isoform expression in acute vs. chronic anti-Thy 1 nephritis. Kidney Int 2002; 61: 826-833.
45. Haruna Y, Kashihara N, Satoh M et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 2007; 104: 2331-2336.
46. Matsuda H, Fukuda N, Ueno T et al. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-beta1 promoter. Kidney Int 79: 46-56.
47. Satoh M, Fujimoto S, Horike H et al. Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney. Lab Invest 2011; 91: 190-202.